Description

Medogystin (betahistine dihydrochloride) tablets 24 mg. №30

Ingredients:

Each tablet contains 24 mg of betahistine dihydrochloride as the active ingredient.

Dosage:

The recommended dosage is one tablet three times a day with meals.

Indications:

Medogystin is indicated for the treatment of Meniere’s disease and vertigo associated with vestibular disorders.

Contraindications:

Do not use Medogystin if you are allergic to betahistine or any other ingredients in the tablets.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Betahistine, the active ingredient in Medogystin, is known to improve inner ear circulation and reduce the frequency and severity of vertigo attacks. Studies have shown that betahistine can effectively alleviate symptoms of Meniere’s disease, such as vertigo, tinnitus, and hearing loss.

Additional Information:

Medogystin tablets have been well-tolerated in clinical trials with minimal side effects reported. It is important to follow the prescribed dosage and consult a healthcare professional before starting any new medication.

Research published in the International Journal of Audiology demonstrated the efficacy of betahistine in improving vestibular function and reducing the impact of vertigo on daily activities. Patients treated with betahistine showed significant improvements in vertigo symptoms compared to placebo.